Acquisition-hungry Valeant Pharmaceuticals International Inc said it agreed to purchase Russian pharma company Natur Produkt International, JSC for about $180 million to tap into the over-the-counter (OTC) market in the country.The deal also includes an additional $5 million in potential future milestones and is expected to close by mid-year 2012, Valeant said in a statement.Natur Produkt, which was founded in 1993, owns brands such as AntiGrippin cough and cold remedy and Anti Angin, Sage and Eucaplyptus MA sore throat treatments.Earlier this month, Valeant bought some assets of Austrian pharmaceutical company Gerot Lannach, and in February, said it had agreed to buy Eyetech Inc and Brazil's Probiotica Laboratorios Ltd.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 1.27% or $0.68/share to $54.38. In the past year, the shares have traded as low as $33.91 and as high as $55.24. On average, 631684 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 49329.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 1.99% or $1.07/share to $54.82. In the past year, the shares have traded as low as $32.05 and as high as $57.24. On average, 1891980 shares of VRX exchange hands on a given day and today's volume is recorded at 168271.
Source
